BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34872608)

  • 1. Pneumocystis jirovecii pneumonia in COVID-19: an overlooked clinical entity-Response to "Pneumocystis pneumonia risk among viral acute respiratory distress syndrome related or not to COVID 19".
    Buonomo AR; Viceconte G; Gentile I
    Crit Care; 2021 Dec; 25(1):418. PubMed ID: 34872608
    [No Abstract]   [Full Text] [Related]  

  • 2. Pneumocystis pneumonia risk among viral acute respiratory distress syndrome related or not to COVID 19.
    Razazi K; Arrestier R; Haudebourg AF; Botterel F; Mekontso Dessap A;
    Crit Care; 2021 Sep; 25(1):348. PubMed ID: 34565429
    [No Abstract]   [Full Text] [Related]  

  • 3. Concurrent COVID-19 and Pneumocystis jirovecii pneumonia in a severely immunocompromised 25-year-old patient.
    Bhat P; Noval M; Doub JB; Heil E
    Int J Infect Dis; 2020 Oct; 99():119-121. PubMed ID: 32768700
    [No Abstract]   [Full Text] [Related]  

  • 4. Pneumocystis jirovecii Pneumonia and Severe Acute Respiratory Syndrome Coronavirus 2 Coinfection in a Patient With Newly Diagnosed HIV-1 Infection.
    Mang S; Kaddu-Mulindwa D; Metz C; Becker A; Seiler F; Smola S; Maßmann A; Becker SL; Papan C; Bals R; Lepper PM; Danziger G
    Clin Infect Dis; 2021 Apr; 72(8):1487-1489. PubMed ID: 32607564
    [No Abstract]   [Full Text] [Related]  

  • 5. Pneumocystis pneumonia in the COVID-19 pandemic era: similarities and challenges.
    Szydłowicz M; Matos O
    Trends Parasitol; 2021 Oct; 37(10):859-862. PubMed ID: 34364804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Case of COVID-19 and
    Menon AA; Berg DD; Brea EJ; Deutsch AJ; Kidia KK; Thurber EG; Polsky SB; Yeh T; Duskin JA; Holliday AM; Gay EB; Fredenburgh LE
    Am J Respir Crit Care Med; 2020 Jul; 202(1):136-138. PubMed ID: 32412848
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pneumonia by Pneumocystis jirovecii after COVID-19 in non-HIV patient].
    Amparo-Vicente M; Morte E
    Rev Chilena Infectol; 2022 Jun; 39(3):357-360. PubMed ID: 36156700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumocystis jirovecii and SARS-CoV-2 Coinfection as Presentation of X-linked Severe Combined Immunodeficiency.
    Toledano-Revenga J; Zapata-Martínez C; Slöcker-Barrio M; Seoane-Reula ME; Beléndez C; Rincón-López E
    Indian J Pediatr; 2023 Aug; 90(8):832-833. PubMed ID: 37249831
    [No Abstract]   [Full Text] [Related]  

  • 9. The presence of Pneumocystis jirovecii in critically ill patients with COVID-19.
    Alanio A; Dellière S; Voicu S; Bretagne S; Mégarbane B
    J Infect; 2021 Apr; 82(4):84-123. PubMed ID: 33157150
    [No Abstract]   [Full Text] [Related]  

  • 10.
    Gentile I; Viceconte G; Lanzardo A; Zotta I; Zappulo E; Pinchera B; Scotto R; Schiano Moriello N; Foggia M; Giaccone A; Messina G; Salvatore P; Buonomo AR; Federico Ii Covid-Team
    Int J Environ Res Public Health; 2021 Oct; 18(21):. PubMed ID: 34769913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Simultaneous diagnosis and favorable evolution of infection with Pneumocystis jirovecii, SARS-CoV-2 and advanced HIV].
    Larzábal FJ; Vilela A; Brusca S; Saluzzi I; Ghergo GE; Angiono MA
    Medicina (B Aires); 2020; 80(5):554-556. PubMed ID: 33048801
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Viceconte G; Buonomo AR; Lanzardo A; Pinchera B; Zappulo E; Scotto R; Schiano Moriello N; Vargas M; Iacovazzo C; Servillo G; Gentile I;
    Infect Dis (Lond); 2021 May; 53(5):382-385. PubMed ID: 33645461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 and Pneumocystis jirovecii pneumonia: Back to the basics.
    Mouren D; Goyard C; Catherinot E; Givel C; Chabrol A; Tcherakian C; Longchampt E; Vargaftig J; Farfour E; Legal A; Couderc LJ; Salvator H
    Respir Med Res; 2021 May; 79():100814. PubMed ID: 33610911
    [No Abstract]   [Full Text] [Related]  

  • 14. Pneumocystis jirovecii Colonization in Preterm Newborns With Respiratory Distress Syndrome.
    Szydłowicz M; Królak-Olejnik B; Vargas SL; Zajączkowska Ż; Paluszyńska D; Szczygieł A; Matos O; Hendrich AB; Kicia M
    J Infect Dis; 2022 May; 225(10):1807-1810. PubMed ID: 33857302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Not COVID-19, Don't Overlook Pneumocystis in Patients on Gefitinib!
    Barben J; Quipourt V; Vovelle J; Putot A; Manckoundia P
    Curr Oncol; 2021 Feb; 28(1):961-964. PubMed ID: 33617512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin resistant enterococcus bacteremia in a patient with Pneumocystis jiroveci pneumonia, granulocystic sarcoma and acute respiratory distress syndrome.
    Emre JC; Baysak A; Oz AT; Ece G; Arda B; Bacakoglu F
    Pan Afr Med J; 2014; 17():49. PubMed ID: 25018799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Unusual Case of Severe Pneumocystis Jiroveci Pneumonia (PJP) presenting as "Recurrent Cytokine Storm'' following COVID-19 Infection.
    Chakravarthy KK; Cherukuri B; Anne S; Shankar TU; Mohan Reddy GM; Guttikonda N
    J Assoc Physicians India; 2021 May; 69(5):78. PubMed ID: 34189894
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of COVID-19 on the frequency of Pneumocystis jirovecii pneumonia: a monocentric, retrospective, and observational study.
    Del Prete V; Paterno G; Cennamo O; Berrilli F; Di Cave D
    BMC Infect Dis; 2023 Oct; 23(1):693. PubMed ID: 37848811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 or Pnuemocystis jirovecii? A case report.
    González Moyano AB; Medina Ramos L; Del Cañizo Moreira M; Merino de Lucas E; González Lorenzo M; Esteban García-Fontecha M
    Med Intensiva (Engl Ed); 2021 Mar; 45(2):124-126. PubMed ID: 32854989
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19-related Respiratory Failure and Lymphopenia Do Not Seem Associated with Pneumocystosis.
    Blaize M; Mayaux J; Luyt CE; Lampros A; Fekkar A
    Am J Respir Crit Care Med; 2020 Dec; 202(12):1734-1736. PubMed ID: 32941062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.